Bronchospasm medical therapy

Bronchospasm Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Bronchospasm from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bronchospasm medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bronchospasm medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bronchospasm medical therapy
CDC on Bronchospasm medical therapy
Bronchospasm medical therapy in the news
Blogs on Bronchospasm medical therapy
Directions to Hospitals Treating Bronchospasm
Risk calculators and risk factors for Bronchospasm medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Beta 2 Agonists

Beta 2 adrenergic agonists are recommended for bronchospasm.

• Short acting (SABA)
  • Salbutamol
  • Levosalbutamol
• Long acting (LABA)
  • Formoterol
  • Salmeterol
• Others
  • Dopamine
  • Norepinephrine
  • Epinephrine

Muscarinic Acetylcholine Receptor Antagonist

Since the neurotransmitter, acetylcholine, is known to decrease sympathetic response by slowing the heart rate and constricting the smooth muscle tissue; ongoing research and successful clinical trials have shown that agents such as diphenhydramine, atropine and Ipratropium bromide are known to be effective for treating asthma and COPD-related symptoms.